Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Khajehali

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Chemmedchem|August 28, 2020
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine ReceptorManuela Jörg, Elham Khajehali, Emma T van der Westhuizen, et al.
European Journal of Medicinal Chemistry|July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChRManuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
ACS Chemical Neuroscience|June 30, 2026
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse EffectsHuong T M Nguyen, Elham Khajehali, Vi Pham, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
Elife|May 30, 2023
Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamicsZiva Vuckovic, Jinan Wang, Vi Pham, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Chemmedchem|August 28, 2020
Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M<sub>1</sub> Muscarinic Acetylcholine ReceptorManuela Jörg, Elham Khajehali, Emma T van der Westhuizen, et al.
European Journal of Medicinal Chemistry|July 9, 2023
Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M<sub>4</sub> mAChRManuela Jörg, Emma T van der Westhuizen, Yao Lu, et al.
Science Signaling|November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative diseaseLouis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
ACS Chemical Neuroscience|December 15, 2018
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M<sub>1</sub> mAChR: The Determinants of Allosteric ActivityManuela Jörg, Emma T van der Westhuizen, Elham Khajehali, et al.
ACS Chemical Neuroscience|June 30, 2026
Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse EffectsHuong T M Nguyen, Elham Khajehali, Vi Pham, et al.
ACS Pharmacology & Translational Science|March 15, 2019
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs <i>in Vitro</i> and <i>in Vivo</i>Karen J Thompson, Elham Khajehali, Sophie J Bradley, et al.
Elife|May 30, 2023
Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamicsZiva Vuckovic, Jinan Wang, Vi Pham, et al.
Pageof 2